G2G Bio

← All Categories

• Korean Biotech at BIO 2026: Kangstem Courts a Partner as Data Nears July 15, 2026

  Korean drug developers pushed partnering deals at BIO USA 2026, with Kangstem Biotech awaiting late-July Phase 2 data and G2G Bio fresh off its KOSDAQ debut.

  
• Korean Biotech Takes Home-Built Strengths to BIO USA 2026 July 14, 2026

  At BIO USA 2026, Korean biotech leaders from MediSapiens, G2G Bio and Lotte Biologics pitched global partners on capabilities built at home.